Eltivutabart is a humanized monoclonal antibody targeting ENTPD1/CD39. It increases extracellular ATP and reduces immunosuppressive adenosine, thereby promoting antitumor immunity. It is suitable for studying metastatic pancreatic cancer.
Molecular Weight:
145.5
Purity:
95.00%
CAS Number:
[2935496-38-9]
Target:
Phosphatase
* VAT and and shipping costs not included. Errors and price changes excepted